FDA Warning Ozempic Safety Risks and Regulatory Updates
Finance
The FDA has issued multiple warnings regarding Ozempic, focusing on compounding risks, counterfeit products, and off-label use. The agency emphasizes that Ozempic is approved fo...
Open article